Literature DB >> 23742779

Risk factors for the occurrence of insulinoma: a case-control study.

Han-Xiang Zhan1, Lin Cong, Yu-Pei Zhao, Tai-Ping Zhang, Ge Chen.   

Abstract

BACKGROUND: The etiology of insulinoma is poorly understood. Few studies investigated the possible roles of environmental factors and lifestyle in the pathogenesis of insulinoma. The aim of this study is to identify risk factors associated with occurrence of insulinoma in the Chinese population.
METHODS: This study consisted of 196 patients with insulinoma and 233 controls. Demographic information of the patients and controls and risk factors of the disease were analyzed. Univariate and unconditional multivariable logistic regression analyses were made to estimate odds ratios (ORs) and possible risk factors.
RESULTS: Approximately 68.88% (135/196) of the patients were from rural areas in contrast to 10.30% (24/233) of the controls (P<0.0001). This difference was confirmed by the multivariate analysis (OR=4.950; 95% CI: 2.928-8.370). Family history of pancreatic endocrine tumor (OR=16.754; 95% CI: 2.125-132.057) and other cancers (OR=2.360; 95% CI: 1.052-5.291) was also related to a high-risk population of insulinoma.
CONCLUSION: Rural residents or people who have a family history of pancreatic endocrine tumor and other cancers are a high-risk population of insulinoma.

Entities:  

Mesh:

Year:  2013        PMID: 23742779     DOI: 10.1016/s1499-3872(13)60051-x

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  6 in total

1.  Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution.

Authors:  Jishu Wei; Xinchun Liu; Junli Wu; Wenbin Xu; Wentao Gao; Kuirong Jiang; Zhihong Zhang; Yi Miao
Journal:  Langenbecks Arch Surg       Date:  2016-08-19       Impact factor: 3.445

2.  Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective.

Authors:  Giovanna Muscogiuri; Barbara Altieri; Manuela Albertelli; Andrea Dotto; Roberta Modica; Luigi Barrea; Giuseppe Fanciulli; Tiziana Feola; Roberto Baldelli; Rosaria Maddalena Ruggeri; Marco Gallo; Valentina Guarnotta; Pasqualino Malandrino; Erika Messina; Mary Anna Venneri; Elisa Giannetta; Diego Ferone; Annamaria Colao; Antongiulio Faggiano
Journal:  Endocrine       Date:  2020-05-28       Impact factor: 3.633

3.  A malignant cause of hypoglycaemia: a metastatic insulin-secreting pancreatic neuroendocrine carcinoma.

Authors:  Mark Anthony Sandoval; Daveric Pagsisihan; A'Ericson Berberabe; Elaine Gayle Palugod-Lopez
Journal:  BMJ Case Rep       Date:  2016-03-18

4.  Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study.

Authors:  T Feola; G Puliani; F Sesti; R Modica; R Centello; R Minotta; G Cannavale; S Di Meglio; V Di Vito; R Lauretta; M Appetecchia; A Colao; A Lenzi; A M Isidori; A Faggiano; E Giannetta
Journal:  J Endocrinol Invest       Date:  2022-01-18       Impact factor: 4.256

5.  Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study.

Authors:  Qiwen Ben; Jie Zhong; Jian Fei; Haitao Chen; Lifen Yv; Jihong Tan; Yaozong Yuan
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

6.  Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms.

Authors:  Justyna Kikut; Anna Jasińska; Jakub Pobłocki; Jacek Brodowski; Szczuko Małgorzata
Journal:  Nutrients       Date:  2020-06-30       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.